Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management
October 20, 2025 updated by: Virginia Commonwealth University
African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease.
The treatment program being tested in this research study aims to address these factors and increase outcomes for the study population.
The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for a weight loss program in a real-world, community-based setting.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18 and older
- Resident of Petersburg, VA
- Interested in engaging community members in healthy lifestyle changes (e.g., walking, small changes to eating) and willing to engage in these behaviors her/himself
Exclusion Criteria:
- A diagnosis of type 1 diabetes mellitus.
- Currently being treated for cancer.
- Medical conditions that may increase risk for participating in unsupervised exercise, if medical clearance is not provided
- Hospitalization for depression or other psychiatric disorder within the past 12 months.
- Lifetime history of bipolar disorder or psychotic disorder.
- Currently pregnant or lactating, or planning to become pregnant within the study period.
- Current involvement in a weight loss program or current use of weight loss medication.
- Inability to speak, read and write English.
- Planning to move from the Petersburg area within the study period.
- Does not have sufficient numbers of individuals in their social network from which to recruit for the proposed study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Wellness Ambassadors will undergo training to recruit and deliver a lifestyle intervention to members of their social networks.
HCL in the intervention group will deliver the intervention immediately following baseline visits and randomization.
|
Train for, recruit participants into, and lead a 12-week lifestyle intervention delivered via weekly group meetings
|
|
No Intervention: Delayed Intervention
Wellness Ambassadors will undergo training to recruit and deliver a lifestyle intervention to members of their social networks.
HCL in the delayed intervention group will deliver the intervention after 24 week data collection visits are complete.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: House Chat Leaders (HCL)
Time Frame: 18 months
|
The number of house chat leaders successfully recruited, trained, and retained.
|
18 months
|
|
Feasibility: Participants
Time Frame: 18 months
|
The average number of participants recruited by the HCLs.
|
18 months
|
|
Feasibility: Delivery Model
Time Frame: 12 weeks
|
The number of intervention sessions delivered; the number of planned session topics that were covered
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability: Attendance
Time Frame: 12 weeks
|
The average number of sessions attended by participants.
|
12 weeks
|
|
Acceptability: Retention
Time Frame: 12 weeks
|
The average number of HCL and participants who are retained in the program
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Moghboeba Mosavel, PhD, Virginia Commonwealth University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
May 30, 2025
Study Completion (Actual)
May 30, 2025
Study Registration Dates
First Submitted
September 13, 2022
First Submitted That Met QC Criteria
September 13, 2022
First Posted (Actual)
September 16, 2022
Study Record Updates
Last Update Posted (Estimated)
October 22, 2025
Last Update Submitted That Met QC Criteria
October 20, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20024014
- 1R01DK132373 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.